Brand dynamics

Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health

Exploring New Paths in "Greater Health": Healthy Element and Micro-Kang Biology Establish a Joint Research Center for Probiotics

Published Time:

2019-01-21

On January 18, 2019, a launch ceremony for a joint probiotics research center established by Joincare Pharmaceutical Group Industry Co., Ltd. and Jiangsu Weikang Biotechnology Co., Ltd. was grandly held in Shenzhen. Leaders and numerous experts and scholars from Joincare Pharmaceutical Group Industry Co., Ltd., Jiangsu Weikang Biotechnology Co., Ltd., and Huazhong University of Science and Technology attended the launch ceremony, witnessing this important moment.

 

At the launch ceremony, Joincare Pharmaceutical Group Industry Co., Ltd. and Jiangsu Weikang Biotechnology Co., Ltd. announced the establishment of a joint probiotics research center. Both parties will be committed to the application-based research, product development, results transformation, academic exchange, and talent cultivation of probiotics. Leveraging the scientific research strength of Huazhong University of Science and Technology, they will strive to build this research and development center into a nationally influential research institution, actively working towards establishing it as a provincial or even national-level research center, striving to provide higher quality products for consumers. This cooperation marks the establishment of a long-term and stable cooperative relationship between the two parties, laying a solid foundation for the rapid, sustained, and comprehensive development of Health Yuan Pharmaceutical Group in the field of probiotic applications.

 

 

 

Joincare Pharmaceutical Group Industry Co., Ltd. is established in the domestic health industry with substantial capital, high product quality, and excellent service reputation. The company integrates production, manufacturing, scientific research, and independent marketing. With the mission of revitalizing the national pharmaceutical industry and the goal of becoming one of China's best pharmaceutical companies, it has developed into a professional and comprehensive pharmaceutical company covering four major fields: raw materials, OTC, prescription drugs, and health products.

 

 

Jiangsu Weikang Biotechnology Co., Ltd. is a national high-tech enterprise specializing in the research, development, production, and application of probiotics and their derivatives. It owns the country's first high-standard, professional probiotics research institute, has built a top domestic team of experts in the biological food industry, and has established an academician workstation and a national postdoctoral research workstation. It has three chief scientists, nearly 10 doctors, and more than 60 R&D and application engineers. It has established four major probiotics powder research and technology platforms: WecLacTM, WecTechTM, WecPro®, and WecCulTM. It possesses over 4000 self-owned strains, more than 60 patented strains and technologies, and more than 100 strains with clear efficacy. It is the probiotic microbial ecological preparation industrialization base of the National Functional Food Engineering Technology Center and has won the honors of "Suzhou Unicorn Cultivation Enterprise" and "Suzhou Gazelle Enterprise." It has now become a leading domestic enterprise in the research and development and production of probiotics.

 

 

The heads of both companies stated that in the future, the two companies will conduct in-depth and comprehensive cooperation, complementing each other's advantages, actively promoting the development of a batch of new products and technologies with independent intellectual property rights, promoting innovation-driven development, introducing internationally advanced scientific and technological achievements, and jointly working with domestic and foreign R&D forces to significantly enhance the future competitiveness of products in the international market.